Evaluation of the Muscular FORCE in the Upper Limbs of Patients Presenting a Thoracic Outlet Syndrome : Monocentric Case-control Study

Trial Information
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational

The thoracic outlet syndrome is a rare but debilitating pathology, responsible for upper limb pain. Its frequency is probably underestimated because of diagnostic difficulties. This syndrome encompasses several entities including compressions of neurological, venous or arterial origin. In addition to pain, the majority of patients report fatigability and loss of strength in the upper limbs. However, the quantification of this loss of strength and fatigability has hardly been studied. In addition, the rehabilitation treatment is the first-line treatment of this pathology. It most often includes a muscle building phase. In this project, we would like to evaluate the proximal and distal force of patients presenting a thoracic outlet syndrome by comparing them to a population free from any pathology in the upper limbs. This evaluation would involve an isokinetic strength analysis of shoulder rotators at the proximal level, using an isokinetic dynamometer. At the distal level, the evaluation would be done using force clamps. In a second step, we will also be able to evaluate the effects of the reeducation on the strength and the muscular fatigability of the patients presenting a thoracic outlet syndrome.

Am I eligible for this trial?
Participation Requirements
Minimum Age:
Maximum Age:
Healthy Volunteers:
Accepts Healthy Volunteers

• Age> 18 years

• Rehabilitative management of an thoracic outlet syndrome in the physical and rehabilitation department of Nantes University Hospital

• Having given their consent by non-oral opposition.

• Affiliated to a social security scheme

Where is this trial taking place?
Other Locations
CHU Nantes
When is this trial taking place?
Start Date: August 3, 2020
Estimated Completion Date: December 3, 2023
How many participants will be in this trial?
Target number of participants: 300
What treatment is being studied in this trial?
What other conditions are being studied in this trial?

This content was sourced from clinicaltrials.gov